BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:11 AM EDT
367.44quote price arrow down-5.21 (-1.40%)
Volume
4,015
Close
372.65quote price arrow up+17.40 (+4.90%)
Volume
4,540,641
52 week range
58.81 - 464.00
Loading...
  • Open350.39
  • Day High374.85
  • Day Low345.00
  • Prev Close372.65
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low58.81
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap90.375B
  • Shares Out242.52M
  • 10 Day Average Volume2.94M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change357.13

KEY STATS

  • Open350.39
  • Day High374.85
  • Day Low345.00
  • Prev Close372.65
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low58.81
  • 52 Week Low Date09/24/20
  • Market Cap90.375B
  • Shares Out242.52M
  • 10 Day Average Volume2.94M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change357.13

RATIOS/PROFITABILITY

  • EPS (TTM)19.38
  • P/E (TTM)19.23
  • Fwd P/E (NTM)8.66
  • EBITDA (MRQ)7.053B
  • ROE (MRQ)133.85%
  • Revenue (MRQ)9.18B
  • Gross Margin (MRQ)85.01%
  • Net Margin (MRQ)52.41%
  • Debt To Equity (MRQ)21.87%

EVENTS

  • Earnings Date11/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO5:2805:28
Watch CNBC's full interview with Cantor Fitzgerald's Louise Chen and SVB Leerink's Geoff Porges of SVB Leernik

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
449.92+0.04+0.01%
REGN
Regeneron Pharmaceuticals Inc
653.18+1.18+0.18%
BIIB
Biogen Inc
299.69+0.48+0.16%
MRNA
Moderna Inc
440.65+6.19+1.42%
GRFS
Grifols SA
14.45+0.22+1.55%